Matches in Wikidata for { <http://www.wikidata.org/entity/Q57903773> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q57903773 description "im November 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57903773 description "wetenschappelijk artikel" @default.
- Q57903773 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q57903773 name "Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer" @default.
- Q57903773 name "Phase 2 Trial of Nonpegylated Doxorubicin" @default.
- Q57903773 type Item @default.
- Q57903773 label "Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer" @default.
- Q57903773 label "Phase 2 Trial of Nonpegylated Doxorubicin" @default.
- Q57903773 prefLabel "Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer" @default.
- Q57903773 prefLabel "Phase 2 Trial of Nonpegylated Doxorubicin" @default.
- Q57903773 P1433 Q57903773-FC77D457-13BA-4702-8610-36A10C512945 @default.
- Q57903773 P1476 Q57903773-07AEFFAD-324F-4985-A4F5-A2FB424FFC29 @default.
- Q57903773 P2093 Q57903773-4BF56DDF-57A2-465F-8A70-821C09D8C73D @default.
- Q57903773 P2093 Q57903773-A28B2FA7-DF9E-42F2-80E3-42F6572E87DE @default.
- Q57903773 P2093 Q57903773-C1EE1427-285C-4C47-9B63-3F9EC094FD9D @default.
- Q57903773 P2093 Q57903773-C3BFF783-8418-410F-AAC3-F7A6A3539EE2 @default.
- Q57903773 P304 Q57903773-2D4B5950-AED4-4A7C-BF77-C5FDCC5C7C76 @default.
- Q57903773 P31 Q57903773-22EF62F8-D929-4FA5-B1B0-AFBC1230E3A5 @default.
- Q57903773 P356 Q57903773-A8B88B5A-7BAD-4C83-9502-5BFC43B63DAE @default.
- Q57903773 P433 Q57903773-A9B9FB06-6051-4325-BB1C-D94DCE72C646 @default.
- Q57903773 P478 Q57903773-CE0BAD59-FB64-456F-9460-1C7D90480575 @default.
- Q57903773 P50 Q57903773-CAF0D541-4914-404F-82C4-31D29DD9F868 @default.
- Q57903773 P50 Q57903773-DE2191FA-EFD4-491A-AA26-4362A2D00BF8 @default.
- Q57903773 P577 Q57903773-F68BDA8E-8174-4EEA-B955-7EE91F49C9BB @default.
- Q57903773 P698 Q57903773-ED57DEE8-B8A0-4AA6-AEFD-11D87C55049E @default.
- Q57903773 P921 Q57903773-360EB150-7F14-422A-A0A8-348D01854A5E @default.
- Q57903773 P921 Q57903773-6A0D9068-8F93-4B1B-BC87-8B4F1D6EE150 @default.
- Q57903773 P921 Q57903773-F6374EE2-637F-478D-B904-3A18C419802F @default.
- Q57903773 P356 IGC.0B013E31822D754E @default.
- Q57903773 P698 22027749 @default.
- Q57903773 P1433 Q15749181 @default.
- Q57903773 P1476 "Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer" @default.
- Q57903773 P2093 "Adele Pesce" @default.
- Q57903773 P2093 "Alessia Di Legge" @default.
- Q57903773 P2093 "Ilaria Nausica Trivellizzi" @default.
- Q57903773 P2093 "Maria Cristina Moruzzi" @default.
- Q57903773 P304 "1446-1451" @default.
- Q57903773 P31 Q13442814 @default.
- Q57903773 P356 "10.1097/IGC.0B013E31822D754E" @default.
- Q57903773 P433 "8" @default.
- Q57903773 P478 "21" @default.
- Q57903773 P50 Q38524419 @default.
- Q57903773 P50 Q91909477 @default.
- Q57903773 P577 "2011-11-01T00:00:00Z" @default.
- Q57903773 P698 "22027749" @default.
- Q57903773 P921 Q18936 @default.
- Q57903773 P921 Q19001098 @default.
- Q57903773 P921 Q42824440 @default.